Improving Financial Health
Recent performance
Highlights
FY21
Growths
Constant FX rates Actual FX rates
Total revenue
7%
4%
Results
USD
US$5,357m
28%
Q1 FY22
Growths
Constant FX rates Actual FX rates
31%
Revenue
Organic revenue
4%
22%
Benchmark EBIT growth
3%
0%
$1,385m
EBIT
Benchmark EBIT margin
25.9%
EPS
Benchmark EPS growth
4%
0%
103.1c
Operating
cash flow
Benchmark operating cash flow conversion
106%
$1,476m
Benchmark operating cash flow growth
22%
Dividend
Total dividend per share growth
0%
47.0c
Funding
and liquidity
Net debt to benchmark EBITDA
2.2x
Certain financial data have been rounded within this presentation. As a result of this rounding, the totals of data presented may vary slightly from the arithmetic totals of such data.
Revenue, Benchmark EBIT growths and Benchmark EBIT margin are on an ongoing activities basis.
1 As at 31 March 2021.
24
Experian Public
experianView entire presentation